Myocardial Solutions (“MSI”) technologies MyoStrain® (fSENC) was featured in a newly published article exploring the effectiveness of cardiovascular magnetic resonance (CMR) and segmental strain to detect ischemia in patients suspected of obstructive coronary artery disease (CAD)...
A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately ...
A new article published in the Journal of Cardiovascular Magnetic Resonance utilized MyoStrain (fast-SENC) to accurately risk-stratify asymptomatic cardiac patients across multiple disease states. The article demonstrated MyoStrain’s clinical utility as a critical risk stratification tool to ...
Myocardial Solutions, Inc. (“MSI”) attended the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th Annual Scientific Sessions, held virtually February 18-20, 2021. This year, SCMR main topics focused on new and traditional use cases of CMR, as well as exploring the use of CMR ...
Myocardial Solutions,Inc. (“MSI”) will attend the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th annual scientific sessions virtually from February 18-21, 2021. The event focuses on highlighting breakthrough developments in new cardiovascular magnetic resonance (CMR) techniques ...
